Early mobilisation in patients with shock and receiving vasoactive drugs in the intensive care unit: A systematic review and meta-analysis of observational studies.

Joan Ramón Masclans, Daniel Molano-Franco, Henry Mauricio Parada-Gereda, Luis F Pardo-Cocuy, Janneth Milena Avendaño

Journal: Medicina intensiva 2025;49(4):193-204

PMID: 39551690

Abstract

OBJECTIVE

The aim of the study was to assess the feasibility and safety of early mobilisation in patients with shock requiring vasoactive drugs in the intensive care unit (ICU).

DESIGN

Systematic review and meta-analysis.

SETTING

Intensive care unit (ICU).

PATIENTS OR PARTICIPANTS

Adult patients requiring vasoactive drugs who received early mobilisation in the intensive care unit.

INTERVENTIONS

A systematic search was conducted using the databases PubMed, Cochrane Library, Scopus, Medline Ovid, Science Direct, and CINAHL, including observational studies involving adult patients requiring vasoactive drugs who received early mobilisation. A meta-analysis was performed on the proportion of safety events and the proportion of early mobilisation in patients with high, moderate, and low doses of vasoactive drugs.

MAIN VARIABLES OF INTEREST

Feasibility, safety events, and the maximum level of activity achieved during early mobilisation.

RESULTS

The search yielded 1875 studies, of which 8 were included in the systematic review and 5 in the meta-analysis. The results showed that 64% (95% CI: 34%-95%, p<0.05) of patients were mobilised with low doses of vasoactive drugs, 30% (95% CI: 7%-53%, p<0.05) with moderate doses, and 7% (95% CI: 3%-16%, p 0.17) with high doses. The proportion of adverse events was low, at 2% (95% CI: 1%-4%, p<0.05).

CONCLUSIONS

Early mobilisation in patients with shock and the need for vasoactive drugs is feasible and generally safe. However, there is an emphasis on the need for further high-quality research to confirm these findings.

Copyright © 2024 Elsevier España, S.L.U. and SEMICYUC. All rights reserved.

Address: Unidad de Cuidado Intensivo Clínica Reina Sofia, Clínica Colsanitas, Grupo de Investigación en Nutrición Clínica y Rehabilitación, Grupo Keralty, Fundacion Universitaria Sanitas, Bogotá, Colombia. Electronic address: [email protected].; Unidad de Cuidado Intensivo Hospital Universitario Mederi Mayor, Universidad del Rosario, Bogotá, Colombia.; Unidad de Cuidado Intensivo Clínica Reina Sofia Pediátrica y Mujer, Clínica Colsanitas, Grupo de Investigación en Nutrición Clínica y Rehabilitación, Fundacion Universitaria Sanitas, Grupo Keralty, Bogotá, Colombia.; Intensive Care Unit Los Cobos Medical Center- Hospital San José, Research Group Gribos, Bogotá, Colombia.; Critical Care Department, Hospital Del Mar Barcelona, Spain, Critical Care Illness Research Group (GREPAC), IMIM, Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.